Regulatory & Legal

A groundbreaking clinical trial shows a nutrition-based therapy extended life by 34% in stage IV pancreatic cancer patients, offering rare hope.

A new AI-powered platform, Scam.org, unites global partners to combat the trillion-dollar scam industry, offering free help in over 50 languages.

Acquisition from Cipriani Energy Group signals major growth in community solar, driven by strategic investment and supportive state policies.

The biopharma nonprofit will tackle clinical trial modernization, AI integration, and the unfulfilled promise of real-world evidence at a key industry summit.

Jason Ellis announces his 2026 retirement, capping a 22-year tenure that saw massive growth and a pivotal shift to private ownership for the mortgage giant.

After a public scare over product safety, hygiene giant Softcare is officially cleared in Senegal, reinforcing its strategy in Africa's competitive market.

A plant-based gel that stops severe bleeding in seconds is being showcased to top trauma experts, signaling a major shift in emergency medicine.

Blackline Safety posts record Q1 revenue, fueled by its booming recurring service model and new connected safety tech, despite a dip in US product sales.

With new clinical data and a clear path to Phase 2 trials, Gain Therapeutics' GT-02287 offers hope for a disease-modifying therapy for Parkinson's.

A new study reveals Edge Copper's Zonia project is a highly profitable US copper source, but can the junior company secure the $524M to build it?

With its earnings call set for March 26, Designer Brands faces a crucial moment. Can its new strategies overcome a tough market and deliver on growth?

A new clinical trial begins for APAC, a first-in-class drug aiming to prevent amputation and death from severe peripheral artery disease.

Semiconductor leader Melexis launches an autonomous China entity, aiming to dominate the EV and robotics markets by operating at local market velocity.

A new platform using tokenized government bonds promises to eliminate billions in fees for businesses, offering instant, low-cost dollar-to-peso conversions.

As North American trade enters a critical USMCA review, a high-stakes summit in Laredo will gather leaders to navigate new tariffs and logistics demands.

The organic retail giant is coming to Walla Walla, promising high standards and good jobs. A closer look reveals a complex picture for the community.

After a massive divestiture and balance sheet overhaul, Elutia is all-in on its next-gen biomatrix, NXT-41x, to disrupt the $1.5B breast surgery market.

Spire Global's appointment of John Martinez signals an aggressive strategy to expand its 'sovereign-ready' space intelligence for government clients.

Positive Phase 3 results for BBP-418 offer a potential first-ever treatment for LGMD2I/R9, a progressive muscle disease with no current therapies.

Industry pioneer Lee Leichter joins EdgeOne Medical, a strategic move to master the complex, high-stakes world of combination product regulation.